Jinlu Jie (金路捷)金路捷

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

%人血白蛋白作保护剂是一种在国家药监局注册认定的药品。标注生产企业为武汉海特生物制药股份有限公司。

该药品暂无关联的活性成分信息。

该药品标注的生产企业为:武汉海特生物制药股份有限公司Chinese legal name: 武汉海特生物制药股份有限公司、武汉海特生物制药股份有限公司Chinese legal name: 武汉海特生物制药股份有限公司、武汉海特生物制药股份有限公司Chinese legal name: 武汉海特生物制药股份有限公司。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 金路捷) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 武汉海特生物制药股份有限公司.

No active ingredient relationships are currently recorded for this product in MedicineGraph.

Manufacturers recorded for this product: 武汉海特生物制药股份有限公司Chinese legal name: 武汉海特生物制药股份有限公司, 武汉海特生物制药股份有限公司Chinese legal name: 武汉海特生物制药股份有限公司, 武汉海特生物制药股份有限公司Chinese legal name: 武汉海特生物制药股份有限公司.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 金路捷Recorded Chinese name: 金路捷
  • 剂型Dosage form: 注射剂Injection
  • 规格Specification: 20μg(≥9000AU)/支Recorded Chinese specification: 20μg(≥9000AU)/支

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

生产企业Manufacturer

  • 武汉海特生物制药股份有限公司Chinese legal name: 武汉海特生物制药股份有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字S20060051

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字S20060051

Manufacturer

Chinese legal name: 武汉海特生物制药股份有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字S20060051

生产企业

武汉海特生物制药股份有限公司(国产)

适应症

用于治疗正己烷中毒性周围神经病。||本品通过促进神经损伤恢复发挥作用。

用法用量

本品用2ml注射用水溶解,肌肉注射。一天一次,每次一瓶(20μg),四周为一疗程,根据病情轻重可遵医嘱多疗程连续给药。

不良反应

1.无严重不良反应。临床试验中发现有个别患者出现一过性转氨酶升高。2.用药后常见注射部位痛或注射侧下肢疼痛(发生率分别为85%和29%),一般不需处理,个别症状较重者,口服镇痛剂即可缓解。3.偶见其它症状(如头晕、失眠等),发生率与安慰剂组比较无明显差别。

禁忌

对本品过敏者禁用。

注意事项

1.过敏体质者慎用。2.本品加注射用水振荡后即可完全溶解,如有不溶的沉淀、混浊或絮状物时不可使用。3.使用前应仔细检查药瓶,如有裂缝或破损等异常情况时不可使用。4.用药过程中,如有任何不适症状及时与医生联系询问。

贮藏

2~8℃避光保存。

规格

20μg(≥9000AU)/支

证据Evidence

  • 批准文号: 国药准字S20060051
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.